The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis
Open accessAbstract
In the dynamic landscape of drug discovery, Computer-Aided Drug Design (CADD) emerges as a transformative force, bridging the realms of biology and technology. This paper overviews CADDs historical evolution, categorization into structure-based and ligand-based approaches, and its crucial role in rationalizing and expediting drug discovery. As CADD advances, incorporating diverse biological data and ensuring data privacy become paramount. Challenges persist, demanding the optimization of algorithms and robust ethical frameworks. Integrating Machine Learning and Artificial Intelligence amplifies CADDs predictive capabilities, yet ethical considerations and scalability challenges linger. Collaborative efforts and global initiatives, exemplified by platforms like Open-Source Malaria, underscore the democratization of drug discovery. The convergence of CADD with personalized medicine offers tailored therapeutic solutions, though ethical dilemmas and accessibility concerns must be navigated. Emerging technologies like quantum computing, immersive technologies, and green chemistry promise to redefine the future of CADD. The trajectory of CADD, marked by rapid advancements, anticipates challenges in ensuring accuracy, addressing biases in AI, and incorporating sustainability metrics. This paper concludes by highlighting the need for proactive measures in navigating the ethical, technological, and educational frontiers of CADD to shape a healthier, brighter future in drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,486
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
High-performance medicine: the convergence of human and artificial intelligence
Topol, E. J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0300-7 · Cited by 10,450
GROMACS: A message-passing parallel molecular dynamics implementation
Berendsen, H. J. C., van der Spoel, D., & van Drunen, R. (1995) · Computer Physics Communications · doi:10.1016/0010-4655(95)00042-e · Cited by 10,405
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
The Amber biomolecular simulation programs
Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., Onufriev, A., Simmerling, C., Wang, B., & Woods, R. J. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20290 · Cited by 9,535
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847
Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9644-8 · Cited by 6,006
Accurate prediction of protein structures and interactions using a 3-track network
Baek, M., DiMaio, F., Anishchenko, I., Dauparas, J., Ovchinnikov, S., Lee, G. R., Wang, J., Cong, Q., Kinch, L. N., Schaeffer, R. D., et al. (2021) · doi:10.1101/2021.06.14.448402 · Cited by 5,549
Green Chemistry: Principles and Practice
Anastas, P., & Eghbali, N. (2010) · Chem. Soc. Rev. · doi:10.1039/b918763b · Cited by 5,256
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
1,500 scientists lift the lid on reproducibility
Baker, M. (2016) · Nature · doi:10.1038/533452a · Cited by 4,209
Docking and scoring in virtual screening for drug discovery: methods and applications
Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1549 · Cited by 4,150
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011) · Current Computer Aided-Drug Design · doi:10.2174/157340911795677602 · Cited by 3,771
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Applications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
The EU General Data Protection Regulation (GDPR)
Voigt, P., & von dem Bussche, A. (2017) · doi:10.1007/978-3-319-57959-7 · Cited by 3,001
Multi-omics approaches to disease
Hasin, Y., Seldin, M., & Lusis, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1215-1 · Cited by 2,953
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
OpenMM 7: Rapid development of high performance algorithms for molecular dynamics
Eastman, P., Swails, J., Chodera, J. D., McGibbon, R. T., Zhao, Y., Beauchamp, K. A., Wang, L.-P., Simmonett, A. C., Harrigan, M. P., Stern, C. D., et al. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005659 · Cited by 2,748
Model Cards for Model Reporting
Mitchell, M., Wu, S., Zaldivar, A., Barnes, P., Vasserman, L., Hutchinson, B., Spitzer, E., Raji, I. D., & Gebru, T. (2019) · Proceedings of the Conference on Fairness, Accountability, and Transparency · doi:10.1145/3287560.3287596 · Cited by 2,681
Molecular Docking: Shifting Paradigms in Drug Discovery
Pinzi, L., & Rastelli, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184331 · Cited by 2,344
Opportunities and obstacles for deep learning in biology and medicine
Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., Ferrero, E., Agapow, P.-M., Zietz, M., Hoffman, M. M., et al. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0387 · Cited by 2,310
A draft map of the human proteome
Kim, M.-S., Pinto, S. M., Getnet, D., Nirujogi, R. S., Manda, S. S., Chaerkady, R., Madugundu, A. K., Kelkar, D. S., Isserlin, R., Jain, S., et al. (2014) · Nature · doi:10.1038/nature13302 · Cited by 2,198
Protein structure prediction and analysis using the Robetta server
Kim, D. E., Chivian, D., & Baker, D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh468 · Cited by 2,111
The Path to Personalized Medicine
Hamburg, M. A., & Collins, F. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1006304 · Cited by 1,970
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
Nicholson, J. K., & Lindon, J. C. (2008) · Nature · doi:10.1038/4551054a · Cited by 1,886
A Critical Assessment of Docking Programs and Scoring Functions
Warren, G. L., Andrews, C. W., Capelli, A.-M., Clarke, B., LaLonde, J., Lambert, M. H., Lindvall, M., Nevins, N., Semus, S. F., Senger, S., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050362n · Cited by 1,814
Drost, J., & Clevers, H. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0007-6 · Cited by 1,790
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Donanemab in Early Alzheimer’s Disease
Mintun, M. A., Lo, A. C., Duggan Evans, C., Wessels, A. M., Ardayfio, P. A., Andersen, S. W., Shcherbinin, S., Sparks, J., Sims, J. R., Brys, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100708 · Cited by 1,728
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules.
Gómez‐Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera‐Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru‐Guzik, A. (2018) · Cambridge University Engineering Department Publications Database · doi:10.17863/cam.34134 · Cited by 1,703
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668
Multi-omics Data Integration, Interpretation, and Its Application
Subramanian, I., Verma, S., Kumar, S., Jere, A., & Anamika, K. (2020) · Bioinformatics and Biology Insights · doi:10.1177/1177932219899051 · Cited by 1,609
Quantum Chemistry in the Age of Quantum Computing
Cao, Y., Romero, J., Olson, J. P., Degroote, M., Johnson, P. D., Kieferová, M., Kivlichan, I. D., Menke, T., Peropadre, B., Sawaya, N. P. D., et al. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00803 · Cited by 1,560
The Many Roles of Computation in Drug Discovery
Jorgensen, W. L. (2004) · Science · doi:10.1126/science.1096361 · Cited by 1,554
Emerging applications of metabolomics in drug discovery and precision medicine
Wishart, D. S. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.32 · Cited by 1,488
Virtual screening of chemical libraries
Shoichet, B. K. (2004) · Nature · doi:10.1038/nature03197 · Cited by 1,425
Improved protein structure prediction using predicted interresidue orientations
Yang, J., Anishchenko, I., Park, H., Peng, Z., Ovchinnikov, S., & Baker, D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914677117 · Cited by 1,421
Rahwan, I., Cebrian, M., Obradovich, N., Bongard, J., Bonnefon, J.-F., Breazeal, C., Crandall, J. W., Christakis, N. A., Couzin, I. D., Jackson, M. O., et al. (2019) · Nature · doi:10.1038/s41586-019-1138-y · Cited by 1,364
Impact of high-throughput screening in biomedical research
Macarron, R., Banks, M. N., Bojanic, D., Burns, D. J., Cirovic, D. A., Garyantes, T., Green, D. V. S., Hertzberg, R. P., Janzen, W. P., Paslay, J. W., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3368 · Cited by 1,364
Lessons from the Cancer Genome
Garraway, L. A., & Lander, E. S. (2013) · Cell · doi:10.1016/j.cell.2013.03.002 · Cited by 1,308
Molecular Dynamics: Survey of Methods for Simulating the Activity of Proteins
Adcock, S. A., & McCammon, J. A. (2006) · Chemical Reviews · doi:10.1021/cr040426m · Cited by 1,272
Quantum Chemistry in the Age of Quantum Computing
Cao, Y., Romero, J., Olson, J., Degroote, M., Johnson, P., Kieferová, M., Kivlichan, I., Menke, T., Peropadre, B., Sawaya, N., et al. (n.d.) · OPUS - Open Publications of UTS Scholars (University of Technology Sydney) · Cited by 1,265
The Rise of Consumer Health Wearables: Promises and Barriers
Piwek, L., Ellis, D. A., Andrews, S., & Joinson, A. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001953 · Cited by 1,235
Biomolecular Simulation: A Computational Microscope for Molecular Biology
Dror, R. O., Dirks, R. M., Grossman, J. P., Xu, H., & Shaw, D. E. (2012) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-042910-155245 · Cited by 1,198
DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases
Ewing, T. J. A., Makino, S., Skillman, A. G., & Kuntz, I. D. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1011115820450 · Cited by 1,187
Integrative omics for health and disease
Karczewski, K. J., & Snyder, M. P. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2018.4 · Cited by 1,158
Molecular dynamics simulations in biology
Karplus, M., & Petsko, G. A. (1990) · Nature · doi:10.1038/347631a0 · Cited by 1,152
Morris, G. M., & Lim-Wilby, M. (2008) · Methods in Molecular Biology · doi:10.1007/978-1-59745-177-2_19 · Cited by 1,099
DeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081
LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites
Venkatachalam, C. M., Jiang, X., Oldfield, T., & Waldman, M. (2003) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(02)00164-x · Cited by 1,002
Computer-based de novo design of drug-like molecules
Schneider, G., & Fechner, U. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1799 · Cited by 948
Integration of virtual and high-throughput screening
Bajorath, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd941 · Cited by 930
ACEMD: Accelerating Biomolecular Dynamics in the Microsecond Time Scale
Harvey, M. J., Giupponi, G., & Fabritiis, G. D. (2009) · Journal of Chemical Theory and Computation · doi:10.1021/ct9000685 · Cited by 919
Schneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910
Rethinking drug design in the artificial intelligence era
Schneider, P., Walters, W. P., Plowright, A. T., Sieroka, N., Listgarten, J., Goodnow, R. A., Fisher, J., Jansen, J. M., Duca, J. S., Rush, T. S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0050-3 · Cited by 894
Deep learning for computational chemistry
Goh, G. B., Hodas, N. O., & Vishnu, A. (2017) · Journal of Computational Chemistry · doi:10.1002/jcc.24764 · Cited by 809
How Open Science Helps Researchers Succeed
McKiernan, E. C., Bourne, P. E., Brown, C. T., Buck, S., Kenall, A., Lin, J., McDougall, D., Nosek, B. A., Ram, K., Soderberg, C. K., et al. (2016) · eLife · doi:10.7554/elife.16800 · Cited by 798
Cournia, Z., Allen, B., & Sherman, W. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00564 · Cited by 789
From machine learning to deep learning: progress in machine intelligence for rational drug discovery
Zhang, L., Tan, J., Han, D., & Zhu, H. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.08.010 · Cited by 760
Implications of protein flexibility for drug discovery
Teague, S. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1129 · Cited by 755
INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug Design
Wlodawer, A., & Vondrasek, J. (1998) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.27.1.249 · Cited by 734
The trRosetta server for fast and accurate protein structure prediction
Du, Z., Su, H., Wang, W., Ye, L., Wei, H., Peng, Z., Anishchenko, I., Baker, D., & Yang, J. (2021) · Nature Protocols · doi:10.1038/s41596-021-00628-9 · Cited by 715
The war against influenza: discovery and development of sialidase inhibitors
von Itzstein, M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2400 · Cited by 702
Pharmacophore perception, development, and use in drug design
Güner, O. F. (2000) · Medical Entomology and Zoology · Cited by 689
Preparing for Precision Medicine
Mirnezami, R., Nicholson, J., & Darzi, A. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1114866 · Cited by 663
Aliper, A., Plis, S., Artemov, A., Ulloa, A., Mamoshina, P., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00248 · Cited by 610
Exploiting machine learning for end-to-end drug discovery and development
Ekins, S., Puhl, A. C., Zorn, K. M., Lane, T. R., Russo, D. P., Klein, J. J., Hickey, A. J., & Clark, A. M. (2019) · Nature Materials · doi:10.1038/s41563-019-0338-z · Cited by 578
Russell and Burch's 3Rs then and now: the need for clarity in definition and purpose.
Tannenbaum, J., & Bennett, B. T. (2015) · PubMed · Cited by 535
Predicting drug metabolism: experiment and/or computation?
Kirchmair, J., Göller, A. H., Lang, D., Kunze, J., Testa, B., Wilson, I. D., Glen, R. C., & Schneider, G. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4581 · Cited by 502
IBM Watson: How Cognitive Computing Can Be Applied to Big Data Challenges in Life Sciences Research
Chen, Y., Elenee Argentinis, J., & Weber, G. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.12.001 · Cited by 466
Walters, W. P., & Murcko, M. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00003-0 · Cited by 439
Mons, B., Neylon, C., Velterop, J., Dumontier, M., da Silva Santos, L. O. B., & Wilkinson, M. D. (2017) · Information Services and Use · doi:10.3233/isu-170824 · Cited by 417
High-resolution de novo structure prediction from primary sequence
Wu, R., Ding, F., Wang, R., Shen, R., Zhang, X., Luo, S., Su, C., Wu, Z., Xie, Q., Berger, B., et al. (2022) · doi:10.1101/2022.07.21.500999 · Cited by 392
Specific Targeted Therapy of Chronic Myelogenous Leukemia with Imatinib
Deininger, M. W. N., & Druker, B. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.4 · Cited by 365
Ain, Q. U., Aleksandrova, A., Roessler, F. D., & Ballester, P. J. (2015) · WIREs Computational Molecular Science · doi:10.1002/wcms.1225 · Cited by 357
Chemography: The Art of Navigating in Chemical Space
Oprea, T. I., & Gottfries, J. (2001) · Journal of Combinatorial Chemistry · doi:10.1021/cc0000388 · Cited by 353
Kadurin, A., Aliper, A., Kazennov, A., Mamoshina, P., Vanhaelen, Q., Khrabrov, K., & Zhavoronkov, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14073 · Cited by 350
Fréchet ChemNet Distance: A Metric for Generative Models for Molecules in Drug Discovery
Preuer, K., Renz, P., Unterthiner, T., Hochreiter, S., & Klambauer, G. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00234 · Cited by 343
Systems approaches to polypharmacology and drug discovery.
Boran, A. D. W., & Iyengar, R. (2010) · PubMed · Cited by 339
Crowdsourcing—Harnessing the Masses to Advance Health and Medicine, a Systematic Review
Ranard, B. L., Ha, Y. P., Meisel, Z. F., Asch, D. A., Hill, S. S., Becker, L. B., Seymour, A. K., & Merchant, R. M. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2536-8 · Cited by 324
Open PHACTS: semantic interoperability for drug discovery
Williams, A. J., Harland, L., Groth, P., Pettifer, S., Chichester, C., Willighagen, E. L., Evelo, C. T., Blomberg, N., Ecker, G., Goble, C., et al. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.016 · Cited by 321
AI in drug discovery and its clinical relevance
Qureshi, R., Irfan, M., Gondal, T. M., Khan, S., Wu, J., Hadi, M. U., Heymach, J., Le, X., Yan, H., & Alam, T. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17575 · Cited by 319
Wang, Y., Suzek, T., Zhang, J., Wang, J., He, S., Cheng, T., Shoemaker, B. A., Gindulyte, A., & Bryant, S. H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt978 · Cited by 284
Developing β‐secretase inhibitors for treatment of Alzheimer’s disease
Ghosh, A. K., Brindisi, M., & Tang, J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07476.x · Cited by 272
Assessing the impact of generative AI on medicinal chemistry
Walters, W. P., & Murcko, M. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0418-2 · Cited by 262
Open science is a research accelerator
Woelfle, M., Olliaro, P., & Todd, M. H. (2011) · Nature Chemistry · doi:10.1038/nchem.1149 · Cited by 260
Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma
Eichler, H.-G., Pignatti, F., Flamion, B., Leufkens, H., & Breckenridge, A. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2664 · Cited by 229
New machine learning and physics-based scoring functions for drug discovery
Guedes, I. A., Barreto, A. M. S., Marinho, D., Krempser, E., Kuenemann, M. A., Sperandio, O., Dardenne, L. E., & Miteva, M. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-82410-1 · Cited by 215
Towards reproducible computational drug discovery
Schaduangrat, N., Lampa, S., Simeon, S., Gleeson, M. P., Spjuth, O., & Nantasenamat, C. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-0408-x · Cited by 208
Is animal research sufficiently evidence based to be a cornerstone of biomedical research?
Pound, P., & Bracken, M. B. (2014) · BMJ · doi:10.1136/bmj.g3387 · Cited by 207
Scientific workflow systems: Pipeline Pilot and KNIME
Warr, W. A. (2012) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-012-9577-7 · Cited by 184
Melting Point Prediction Employing k-Nearest Neighbor Algorithms and Genetic Parameter Optimization
Nigsch, F., Bender, A., van Buuren, B., Tissen, J., Nigsch, E., & Mitchell, J. B. O. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060149f · Cited by 183
Recent Advances in Machine-Learning-Based Chemoinformatics: A Comprehensive Review
Niazi, S. K., & Mariam, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411488 · Cited by 158
Self-citationInternational Charter of principles for sharing bio-specimens and data
Mascalzoni, D., Dove, E. S., Rubinstein, Y., Dawkins, H. J. S., Kole, A., McCormack, P., Woods, S., Rieß, O., Schaefer, F. S., Lochmüller, H., et al. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.197 · Cited by 155
Network-based machine learning and graph theory algorithms for precision oncology
Zhang, W., CHIEN, J. R., Yong, J., & Kuang, R. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0029-7 · Cited by 155
Sampling molecular conformations and dynamics in a multiuser virtual reality framework
O’Connor, M. B., Deeks, H. M., Dawn, E., Metatla, O., Roudaut, A., Sutton, M., Thomas, L. M., Glowacki, B. R., Sage, R., Tew, P., et al. (2018) · Science Advances · doi:10.1126/sciadv.aat2731 · Cited by 152
Data-driven medicinal chemistry in the era of big data
Lusher, S. J., McGuire, R., van Schaik, R. C., Nicholson, C. D., & de Vlieg, J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.12.004 · Cited by 150
Sharing health data: good intentions are not enough
Pisani, E., & AbouZahr, C. (2010) · Bulletin of the World Health Organization · doi:10.2471/blt.09.074393 · Cited by 142
Takeda, T., Hao, M., Cheng, T., Bryant, S. H., & Wang, Y. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0200-8 · Cited by 130
The economic value of personalized medicine tests: what we know and what we need to know
Phillips, K. A., Sakowski, J. A., Trosman, J. R., Douglas, M. P., Liang, S., & Neumann, P. J. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.122 · Cited by 127
Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies
Bassani, D., & Moro, S. (2023) · Molecules · doi:10.3390/molecules28093906 · Cited by 118
The genetics of drug efficacy: opportunities and challenges
Nelson, M. R., Johnson, T., Warren, L. L., Hughes, A. R., Chissoe, S. L., Xu, C., & Waterworth, D. M. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.12 · Cited by 116
The Innovative Medicines Initiative: A European Response to the Innovation Challenge
Goldman, M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.321 · Cited by 113
Bitencourt‐Ferreira, G., & de Azevedo, W. F. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9752-7_12 · Cited by 103
Andrade, E., Bento, A. F., Cavalli, J., de Oliveira, S. K. F., Freitas, C. S., Marcon, R., Schwanke, R. C., Siqueira, J. M., & Calixto, J. Β. (2016) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20165644 · Cited by 86
Blundell, T. L. (2017) · IUCrJ · doi:10.1107/s2052252517009241 · Cited by 81
Breast cancer cell nuclei classification in histopathology images using deep neural networks
Feng, Y., Zhang, L., & Zhang, Y. (2017) · International Journal of Computer Assisted Radiology and Surgery · doi:10.1007/s11548-017-1663-9 · Cited by 81
Computer-Aided Drug Design in Epigenetics
Lu, W., Zhang, R., Jiang, H., Zhang, H., & Luo, C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00057 · Cited by 77
Artificial intelligence and machine learning for clinical pharmacology
Ryan, D. K., Maclean, R., Balston, A. J., Scourfield, A., Shah, A. D., & Ross, J. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15930 · Cited by 77
Integrated Molecular Modeling and Machine Learning for Drug Design
Xia, S., Chen, E., & Zhang, Y. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.3c00814 · Cited by 75
Gayathiri, E., Prakash, P., Kumaravel, P., Jayaprakash, J., Ragunathan, M. G., Sankar, S., Pandiaraj, S., Thirumalaivasan, N., Thiruvengadam, M., & Rajakumar, G. (2023) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2023.08.002 · Cited by 73
A chemical–genetic interaction map of small molecules using high‐throughput imaging in cancer cells
Breinig, M., Klein, F. A., Huber, W. K., & Boutros, M. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156400 · Cited by 72
Next-Generation Microfluidics for Biomedical Research and Healthcare Applications
Deliorman, M., Ali, D. S., & Qasaimeh, M. A. (2023) · Biomedical Engineering and Computational Biology · doi:10.1177/11795972231214387 · Cited by 64
Literature analysis of artificial intelligence in biomedicine
Hulsen, T. (2022) · Annals of Translational Medicine · doi:10.21037/atm-2022-50 · Cited by 59
Morgera, E., Tsioumani, E., & Buck, M. (2014) · Brill | Nijhoff eBooks · doi:10.1163/9789004217188 · Cited by 58
Review on the use of Molecular Docking as the First Line Tool in Drug Discovery and Development
Sahoo, R., Pattanaik, S. K., Pattnaik, G., Mallick, S. B., & Mohapatra, R. (2022) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.1031 · Cited by 58
An Integrated Virtual Screening Approach for VEGFR-2 Inhibitors
Zhang, Y., Yang, S., Jiao, Y., Liu, H., Yuan, H., Lü, S., Ran, T., Yao, S., Ke, Z., Xu, J., et al. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400429g · Cited by 56
Integrating structural and mutagenesis data to elucidate GPCR ligand binding
Munk, C., Harpsøe, K., Hauser, A. S., Ísberg, V., & Gloriam, D. E. I. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.07.003 · Cited by 53
High-throughput and virtual screening: core lead discovery technologies move towards integration
Good, A. C., Krystek, S. R., & Mason, J. S. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)00015-5 · Cited by 51
Overview of Machine Learning: Part 2
Le, W., Maleki, F., Romero, F. P., Forghani, R., & Kadoury, S. (2020) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2020.06.003 · Cited by 46
A new wave of innovation in Semantic web tools for drug discovery
Kanza, S., & Frey, J. G. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1586880 · Cited by 43
Sullivan, J. A., Dumont, J. R., Memar, S., Skirzewski, M., Wan, J., Mofrad, M. H., Ansari, H. Z., Li, Y., Muller, L., Prado, V. F., et al. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12705 · Cited by 41
Karatzas, E., Zamora, J. E., Athanasiadis, E. I., Dellis, D., Cournia, Z., & Spyrou, G. M. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btz976 · Cited by 39
Fujimoto, K. J., Minami, S., & Yanai, T. (2022) · ACS Omega · doi:10.1021/acsomega.2c02822 · Cited by 37
Transcriptomic Data Mining and Repurposing for Computational Drug Discovery
Wang, Y., Yella, J., & Jegga, A. G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8955-3_5 · Cited by 32
Amir, S., Arathi, A., Reshma, S. C., & Mohanan, P. V. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123784 · Cited by 31
Branković, M. (2023) · Analytical Methods · doi:10.1039/d3ay01644g · Cited by 30
Luo, M., Wang, X. S., & Tropsha, A. (2015) · Molecular Informatics · doi:10.1002/minf.201500038 · Cited by 27
A new crystal structure fragment-based pharmacophore method for G protein-coupled receptors
Fidom, K., Ísberg, V., Hauser, A. S., Mordalski, S., Lehto, T., Bojarski, A. J., & Gloriam, D. E. I. (2014) · Methods · doi:10.1016/j.ymeth.2014.09.009 · Cited by 21
The quest for novel chemical matter and the contribution of computer-aidedde novodesign
Pirard, B. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.554394 · Cited by 19
Fu, C., Xiang, M.-L., Chen, S.-L., Dong, G., Liu, Z., Chen, C., Liang, J., Cao, Y., Zhang, M., & Liu, Q. (2023) · ACS Omega · doi:10.1021/acsomega.3c02082 · Cited by 14
Quantitative Systems Pharmacology and Machine Learning: A Match Made in Heaven or Hell?
Tindall, M. J., Cucurull-Sanchez, L., Mistry, H. B., & Yates, J. W. T. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001551 · Cited by 14
Deep Learning and Computational Chemistry
James, T., & Hristozov, D. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1787-8_5 · Cited by 10
Gierend, K., Waltemath, D., Ganslandt, T., et al. (2023) · JMIR Formative Research · doi:10.2196/50027 · Cited by 8
Reinventing Therapeutic Proteins: Mining a Treasure of New Therapies
Niazi, S. K., & Mariam, Z. (2023) · Biologics · doi:10.3390/biologics3020005 · Cited by 5
Self-citationShabani, A., Rajabi, S., Alipanahi, N., & Teymourlouy, A. A. (2022) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.36.117 · Cited by 2
Research works printed but not linked: 23
- Johnson, 1995, Historical perspectives in drug discovery: The advent of computational tools, J. Drug Discov., 12, 5
- Patel, 2003, Modeling drug-receptor interactions: Advances and challenges, J. Med. Chem., 46, 2543
- Green, 2010, Structural biology and computational chemistry: A symbiotic relationship, Chem. Rev., 110, 5678
- Walker, 1997, Zanamivir: The making of a drug, Nat. Biotechnol., 15, 232
- Martinez, 2006, Computational strategies in drug design, Drug Discov. Today, 11, 149
- Kapoor, 2018, From empirical to rational drug discovery: The importance of CADD, Drug Des. Rev., 15, 345
- Thompson, 2004, Techniques in Computer-Aided Drug Design, Bioorganic Med. Chem., 12, 3101
- Leach, 2007, Molecular modeling: Principles and applications, J. Chem. Inf. Model., 47, 5
- Lin, Z., Akin, H., Rao, R., Hie, B., Zhu, Z., Lu, W., Smetanin, N., Verkuil, R., Kabeli, O., and Shmueli, Y. (2022). Language models of protein sequences at the scale of evolution enable accurate structure prediction. bioRxiv, 2020.
- Willett, 2006, Virtual screening using molecular docking, Drug Discov. Today Technol., 3, 229
- Raj, 2011, 3d QSAR studies in conjunction with k-nearest neighbor molecular field analysis (k-NN-MFA) on a series of substituted 2-phenyl-benzimidazole derivatives as an anti allergic agents, Dig. J. Nanomater. Biostructures, 6, 1811
- Ekins, 2007, In silico pharmacokinetics: ADME in drug discovery, Drug Discov. World, 8, 17
- Zhang, 2019, AI and its role in drug discovery, J. Drug Discov. Des., 5, 1
- Bishop, C.M. (2006). Pattern Recognition and Machine Learning, Springer.
- Harper, 2014, Recent advances in the discovery of small molecule inhibitors of hepatitis C virus, Annu. Rev. Pharmacol. Toxicol., 54, 317
- Rani, 2022, Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Ann. Med. Surg., 80, 104125, 10.1016/j.amsu.2022.104125 · doi:10.1016/j.amsu.2022.104125
- Bhardwaj, 2011, Open source drug discovery—A new paradigm of collaborative research in tuberculosis drug development, Tuberculosis, 91, 479
- Brownsword, R., and Goodwin, M. (2012). Law and the Technologies of the Twenty-First Century, Cambridge University Press. · doi:10.1017/cbo9781139047609
- Torrance, 2019, Patents and the Regress of Useful Arts, Columbia Sci. Technol. Law Rev., 10, 130
- Lyon, 2019, AI ethics in predictive modeling and precision medicine, J. Mol. Biol., 431, 4118
- Shultz, 2019, Considerations for designing and prioritizing computational drug discovery, SLAS Discov., 24, 468
- Monge, 2011, University–industry collaboration in drug discovery and developments: A matter of synergies, Drug Discov. Today, 16, 1106
- Vapnik, V. (2013). The Nature of Statistical Learning Theory, Springer.
Cited by
Advancing pharmaceutical research: A comprehensive review of cutting-edge tools and technologies
Chen, J., Lin, A., & Luo, P. (2024) · Current Pharmaceutical Analysis · doi:10.1016/j.cpan.2024.11.001 · Cited by 112
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18091271 · Cited by 61
Self-citation
Metadata
- Authors
- Niazi, S. K., & Mariam, Z.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2023-12-22
- Volume
- 17
- Issue
- 1
- Pages
- 22
- ISSN
- 1424-8247 (ISSN-L)
- OpenAlex
- W4390114224
- Cited by
- 336
- References
- 147
- FWCI
- 44.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.